CAS: 3952-98-5; Potassium (1-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(Hydroxymethyl)Tetrahydro-2H-Pyran-2-yl)Thio)But-3-En-1-Ylidene)Amino Sulfate

该化合物是一种天然的甘蓝蛋白,主要存在于芥子种子,布鲁塞尔芽芽和卷心菜等十字架蔬菜中,一种无色的黄色晶状固体,在水中可溶解并表现出微薄的味道.西尼格林因其在植物防御机制中的作用而闻名,有助于芥子气和相关植物的特质和芳香.在水解过程中,西尼格林可产生甘蔗,硫磺和其他生物活性化合物,已经研究过这些植物的潜在健康惠益,包括抗氧化剂和抗癌特性.该物质在正常条件下保持稳定,但在暴露于高温或极端pH水平时可以分解.西尼格林单体水酸对食品科学和营养也感兴趣,因为它可能影响来自其来源植物的食品的营养状况.其应用范围扩大到农业,食品保护以及健康和医药的潜在治疗用途.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号109-73-9 正丁胺 | CAS号625-38-7 乙烯基乙酸 | CAS号7803-49-8 羟胺 | CAS号109-75-1 3-丁烯腈 | CAS号50-99-7 D(+)-无水葡萄糖 | CAS号764-49-8 allyl thi°Cyanate

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-5286877-A
    优先权日:1993-02-01
    标 题:Synthesis of 1,4-dideoxy-1,4-imino-L-arabinitol
    发明人:BEHLING JAMES R; MEDICH JOHN R; BABIAK KEVIN A; FLEET GEORGE W J
    权利人:SEARLE & CO
    摘要:1,4-Dideoxy-1,4-imino-L-arabinitol is chemically synthesized from D-lyxonolactone by formation of the pyrrolidine ring by joining the nitrogen between C-1 and C-4 and inversion of configuration at both C-2 and C-4, with the C-3 and C-5 hydroxyl groups being protected throughout the synthesis sequence by benzylidenation. The product is preferably isolated as the hydrochloride salt and is useful as an inhibitor of α-glucosidase and human immunodeficiency virus (HIV).

    专利号:US-7250559-B2
    优先权日:2001-07-05
    标 题:Nucleic acids encoding glucosinolate biosynthesis enzymes and methods of their use
    发明人:QUIROS CARLOS; LI GENYI
    权利人:UNIV CALIFORNIA
    摘要:Provided are nucleic acid sequences from Brassica oleracea plants that encode enzymes involved in the synthesis of a glucosinolate molecule, including BoGSL-ALK, and BoGSL-ELONG, and methods of their use. The sequences find particular use in modifying the glucosinolate content of a plant. Also provided are primers for these two genes and a third key gene in the glucosinolate pathway, BoGSL-PRO, that can be used for developing molecular markers for assisted selection of plants with specific glucosinolate compositions. Additionally, compositions and methods for a simple, reliable and efficient PCR-based marker system, named sequence-related amplification polymorphism (SRAP), that finds use in the identification of coding sequences in the genome of a plant are provided.

    专利号:US-2014357576-A1
    优先权日:2013-05-31
    标题:Methods for enhancement of muscle protein synthesis
    发明人:BREUILLE DENIS; STELLINGWERFF TRENT; MOORE DANIEL RYAN; OFFORD CAVIN ELIZABETH ANN; PHILLIPS STUART MARTIN
    权利人:NESTEC SA
    摘要:The present disclosure provides methods for enhancing muscle protein synthesis in an individual in need of same. Specifically, the present disclosure provides methods for enhancing muscle protein synthesis by enhancing myofibrillar muscle protein synthesis. The method includes administering to the individual a mixed macronutrient composition having (i) an amount of whey protein that is not capable of enhancing myofibrillar protein synthesis when ingested by itself and (ii) free leucine. The composition comprises at least about 5.0 g total leucine per dose.

    专利号:WO-2015040533-A1
    优先权日:2013-09-19
    标题:Methods for enhancing muscle protein synthesis during energy deficit
    发明人:BAILEY DAVID MARK; ZALTAS ERIC SCOTT; STELLINGWERFF TRENT; MOORE DANIEL RYAN; HAWLEY JOHN ALAN; BURKE LOUISE MARY
    权利人:PREMIER NUTRITION CORP
    摘要:The present disclosure provides methods for enhancing muscle protein synthesis in an individual in need of same. Specifically, the present disclosure provides methods for enhancing muscle protein synthesis during periods of negative energy balance, or energy deficit. The methods include administering to an individual suffering from energy deficit a composition comprising protein in an amount from about 15 g to about 30 g during a time period selected from the group consisting of during exercise, post-exercise, and combinations thereof. The methods also include administering to an individual suffering from energy deficit a composition comprising protein during a time period selected from the group consisting of during exercise, post-exercise, and combinations thereof, wherein the protein is administered in a dose that is higher than doses typically recommended for individuals experiencing energy balance.

    专利号:US-2014294788-A1
    优先权日:2013-03-26
    标 题 :Methods for enhancing muscle protein synthesis following concurrent training
    发明人:BAILEY DAVID MARK; ZALTAS ERIC SCOTT; MOORE DANIEL RYAN; STELLINGWERFF TRENT
    权利人:NESTEC SA
    摘要:The present disclosure provides methods for enhancing muscle protein synthesis following physical exertion. In a general embodiment, a method for enhancing muscle protein synthesis following physical exertion is provided and includes administering to an individual a composition comprising from about 15 to about 35 g protein immediately following concurrent training. Programs for enhancing muscle adaptation resulting from concurrent training are also provided. The programs include providing a composition comprising from about 15 to about 35 g protein; and providing guidelines for consumption including a recommendation of the amount of the composition to consume immediately following concurrent training.

    专利号:WO-2014191856-A1
    优先权日:2013-05-31
    标 题:Methods for enhancement of muscle protein synthesis

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.5281/zenodo.2652993
    摘要:S29 | PHYTOTOXINS | Toxic Plant Phytotoxin (TPPT) Database | DOI:10.5281/zenodo.2652993
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知